Susceptibility to severe COVID-19
- PMID: 33093097
- DOI: 10.1126/science.abe7591
Susceptibility to severe COVID-19
Comment in
-
Interferon deficiency can lead to severe COVID.Nature. 2020 Nov;587(7834):374-376. doi: 10.1038/d41586-020-03070-1. Nature. 2020. PMID: 33139913 No abstract available.
Comment on
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.Science. 2020 Oct 23;370(6515):eabd4570. doi: 10.1126/science.abd4570. Epub 2020 Sep 24. Science. 2020. PMID: 32972995 Free PMC article.
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.Science. 2020 Oct 23;370(6515):eabd4585. doi: 10.1126/science.abd4585. Epub 2020 Sep 24. Science. 2020. PMID: 32972996 Free PMC article.
Similar articles
-
Dysregulation of type I interferon responses in COVID-19.Nat Rev Immunol. 2020 Jul;20(7):397-398. doi: 10.1038/s41577-020-0346-x. Epub 2020 May 26. Nat Rev Immunol. 2020. PMID: 32457522 Free PMC article.
-
Host genetic factors and susceptibility to SARS-CoV-2 infection.Am J Hum Biol. 2020 Sep;32(5):e23497. doi: 10.1002/ajhb.23497. Epub 2020 Sep 2. Am J Hum Biol. 2020. PMID: 32876373 Review. No abstract available.
-
Type I IFN immunoprofiling in COVID-19 patients.J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
-
Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.Signal Transduct Target Ther. 2020 Sep 14;5(1):198. doi: 10.1038/s41392-020-00306-4. Signal Transduct Target Ther. 2020. PMID: 32929061 Free PMC article. No abstract available.
-
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.Braz J Infect Dis. 2020 Sep-Oct;24(5):428-433. doi: 10.1016/j.bjid.2020.07.011. Epub 2020 Aug 26. Braz J Infect Dis. 2020. PMID: 32866437 Free PMC article. Review.
Cited by
-
Deficiency of Tlr7 and Irf7 in mice increases the severity of COVID-19 through the reduced interferon production.Commun Biol. 2024 Sep 17;7(1):1162. doi: 10.1038/s42003-024-06872-5. Commun Biol. 2024. PMID: 39289468 Free PMC article.
-
Type I interferon pathway genetic variants in severe COVID-19.Virus Res. 2024 Apr;342:199339. doi: 10.1016/j.virusres.2024.199339. Epub 2024 Feb 22. Virus Res. 2024. PMID: 38354910 Free PMC article. Review.
-
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.Immunol Rev. 2024 Mar;322(1):98-112. doi: 10.1111/imr.13304. Epub 2024 Jan 9. Immunol Rev. 2024. PMID: 38193358 Review.
-
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis.J Transl Autoimmun. 2023 Oct 14;7:100219. doi: 10.1016/j.jtauto.2023.100219. eCollection 2023 Dec. J Transl Autoimmun. 2023. PMID: 37868109 Free PMC article.
-
Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish Population.Hum Gene (Amst). 2022 Dec;34:201115. doi: 10.1016/j.humgen.2022.201115. Epub 2022 Oct 4. Hum Gene (Amst). 2022. PMID: 37521442 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources